BiotechTubeBiotechTube
Home/Genelux/Dr. Paul Fischer, M.D.
DP

Dr. Paul Fischer, M.D.

Former Chief Medical Officer

Genelux

Therapeutic Areas

Oncology

Genelux Pipeline

DrugIndicationPhase
Olvi-Vec (olvimulogene nanivacirepvec)Platinum-Resistant/Refractory Ovarian CancerPhase 2/3
Olvi-VecSmall Cell Lung Cancer (SCLC)Phase 2
GLX-401Undisclosed Solid TumorsPreclinical

Leadership Team at Genelux

TZ
Thomas Zindrick, J.D., M.B.A.
Chairman of the Board, President & Chief Executive Officer
JL
James L. Tyree
Former Chief Financial Officer
DA
Dr. Aladar A. Szalay, Ph.D.
Founder and Chief Scientific Officer
View full Genelux profile